Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Here's How Much $100 Invested In McKesson 5 Years Ago Would Be Worth Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 5 years by 20.42% on an annualized basis producing an average annual return of 34.18%. Currently, McKesson has a market capitalization of $84.15 billion.
McKesson Corporation ( MCK ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies
Despite tariff headwinds and softer elective procedure demand, McKesson, Cardinal Health, West Pharmaceutical Services, and The Cooper Companies are positioned for steady gains in the dental supplies space.
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies
WASHINGTON, Aug. 8, 2025 /PRNewswire/ -- Pharmacy Profiles, the trusted source for pharmacist identity and credentialing services, today announced a new agreement with McKesson Corporation to provide credential verification services for McKesson's Health Mart independent pharmacy network.
Here's Why McKesson ( MCK ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Dividend Watch: 3 Companies Boosting Payouts
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
McKesson ( MCK ) Surpasses Q1 Earnings and Revenue Estimates
McKesson (MCK) delivered earnings and revenue surprises of +0.36% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?
BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?
MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results?
COR benefits from strong specialty and GLP-1 demand, but Q3 results may face pressure from international weakness.
Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
DIS, BJ, RL, and MCK stand out with strong interest coverage ratios, making them attractive picks in a volatile market.
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.
$100 Invested In McKesson 5 Years Ago Would Be Worth This Much Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 5 years by 21.3% on an annualized basis producing an average annual return of 34.8%. Currently, McKesson has a market capitalization of $87.28 billion.
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
HIMS' second-quarter 2025 results are likely to benefit from subscriber momentum and digital care tools.
Unlocking Q1 Potential of McKesson ( MCK ) : Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why McKesson ( MCK ) Dipped More Than Broader Market Today
McKesson (MCK) reached $693.54 at the closing of the latest trading day, reflecting a -2.99% change compared to its last close.
Earnings Preview: Becton Dickinson ( BDX ) Q3 Earnings Expected to Decline
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Conmed ( CNMD ) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +1.77% and +0.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Why Growth Investors Shouldn't Overlook McKesson ( MCK )
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging McKesson ( MCK ) This Year?
Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About McKesson ( MCK ) : Should You Buy?
The average brokerage recommendation (ABR) for McKesson (MCK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Strength Seen in ProDex ( PDEX ) : Can Its 8.2% Jump Turn into More Strength?
ProDex (PDEX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How Do Investors Really Feel About McKesson? - McKesson ( NYSE:MCK )
McKesson's MCK short percent of float has risen 6.21% since its last report. The company recently reported that it has 2.13 million shares sold short, which is 1.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.58 days to cover their ...
McKesson Corporation ( MCK ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here's Why McKesson ( MCK ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 20 years by 6.3% on an annualized basis producing an average annual return of 14.78%. Currently, McKesson has a market capitalization of $88.72 billion.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
McKesson Corporation ( MCK ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Is First Trust Consumer Staples AlphaDEX ETF ( FXG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Why McKesson ( MCK ) Dipped More Than Broader Market Today
McKesson (MCK) concluded the recent trading session at $724.11, signifying a -1.53% move from its prior day's close.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF ( FXG ) ?
Sector ETF report for ...
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why McKesson ( MCK ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is It Worth Investing in McKesson ( MCK ) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), McKesson (MCK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
McKesson ( MCK ) Stock Falls Amid Market Uptick: What Investors Need to Know
McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
These women-run company stocks offer high growth and stability.
Is McKesson ( MCK ) a Solid Growth Stock? 3 Reasons to Think "Yes"
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
AEM, NTES, QFIN, UGI and MCK stand out as strong dividend growth picks for steady income and upside in 2H25.
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - McKesson ( NYSE:MCK )
McKesson MCK has outperformed the market over the past 15 years by 4.58% on an annualized basis producing an average annual return of 17.22%. Currently, McKesson has a market capitalization of $90.92 billion.
WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus
West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
McKesson Corporation ( MCK ) Is a Trending Stock: Facts to Know Before Betting on It
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
